Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
about
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data.Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study.A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancerChemotherapy Versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-Institutional Propensity Score Matching Analysis.Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.Signaling pathways as therapeutic targets in biliary tract cancer.Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.Promising therapeutics of gastrointestinal cancers in clinical trials.Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer.Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer.Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospects.
P2860
Q31033443-607C1FBB-E5C0-4715-81F6-AAAF5BAECA33Q33438718-985F0190-2FE1-482A-A355-4B37C12C5713Q33738937-E6DE0D5D-D0BE-4042-BBFD-4DF9098843C6Q38609876-AF346167-4078-44D1-8017-61C83C06F4E5Q38673037-1D4745E0-C420-490F-AB2F-0F74F1DA5500Q38701620-94A1076C-63E7-427A-AC31-20C04E355C59Q38747573-2D6128FF-C7A9-4DF7-8A0E-8B1A9C7FCED4Q39012507-3D81EB38-33E0-4A24-BB7E-9981AD5C8CBDQ39025911-7BFDF50F-B607-425A-8D90-DF8CF9E9FDD7Q39453620-FE3ADA7D-6DF7-4772-8990-2E93B03B822EQ39662945-BB7E1858-6287-41D6-8E92-367C3DE25FFAQ47403256-DC7538E3-0D4E-4035-BA3B-EBAE57FCC93DQ48126896-3A4F4F1C-0DCC-4063-B829-4B8BB4E46A96Q48333251-E8EC7A49-F888-4DF0-A637-15A199322BE7Q51763013-96ACEF5F-BEB1-4BE7-8BC8-C15D8C1BA40EQ51799569-F433ED66-7053-47D6-BCA6-889A890C089FQ53579614-1DD71A8C-C308-413E-B9DD-124F458AA1CBQ55223567-852DA7DC-655A-4D8A-94C8-BF12F0E6FF8A
P2860
Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Second-line chemotherapy for a ...... astro-Entérologues Oncologues.
@en
type
label
Second-line chemotherapy for a ...... astro-Entérologues Oncologues.
@en
prefLabel
Second-line chemotherapy for a ...... astro-Entérologues Oncologues.
@en
P2093
P2860
P50
P356
P1433
P1476
Second-line chemotherapy for a ...... Gastro-Entérologues Oncologues
@en
P2093
Anne Thirot-Bidault
Astrid Lièvre
Bertrand Brieau
Florence Mary
Isabelle Trouilloud
Julien Taieb
Jérome Desrame
Laetitia Dahan
Lysiane Marthey
Pauline Soibinet
P2860
P304
P356
10.1002/CNCR.29471
P407
P577
2015-06-05T00:00:00Z